CN103366072A - Digital simulation method for blood backflow caused by mitral valve insufficiency - Google Patents

Digital simulation method for blood backflow caused by mitral valve insufficiency Download PDF

Info

Publication number
CN103366072A
CN103366072A CN201310338575XA CN201310338575A CN103366072A CN 103366072 A CN103366072 A CN 103366072A CN 201310338575X A CN201310338575X A CN 201310338575XA CN 201310338575 A CN201310338575 A CN 201310338575A CN 103366072 A CN103366072 A CN 103366072A
Authority
CN
China
Prior art keywords
node
resistance
mitral valve
circuit
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310338575XA
Other languages
Chinese (zh)
Other versions
CN103366072B (en
Inventor
黄晓阳
赵晓佳
苏茂龙
钟琪
冯敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xiamen University
Original Assignee
Xiamen University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xiamen University filed Critical Xiamen University
Priority to CN201310338575.XA priority Critical patent/CN103366072B/en
Publication of CN103366072A publication Critical patent/CN103366072A/en
Application granted granted Critical
Publication of CN103366072B publication Critical patent/CN103366072B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Prostheses (AREA)

Abstract

一种二尖瓣关闭不全血液返流的数字仿真方法,涉及心血管系统。一、根据血液动力学参数和电路参数之间的等效关系,建立与肺循环系统、体循环系统、左心循环系统、右心循环系统等效的四腔室集总参数心血管动态电路模型;二、根据步骤一建立的电路模型,用状态变量分析法分析建立的动态电路,对电路中相关节点建立相应的状态方程;三、根据仿真的需求,设置步骤一、步骤二中的相应参数,并根据步骤一设置的电路模型以及步骤二设置的状态方程,进行求解状态方程得到电路中个结点时间曲线图;四、对步骤三得到的QM进行计算,得到二尖瓣关闭不全时血液返流量VRM、二尖瓣前向输出量VFM以及二尖瓣容积VM

A method for digital simulation of blood regurgitation in mitral regurgitation involving the cardiovascular system. 1. According to the equivalent relationship between hemodynamic parameters and circuit parameters, establish a four-chamber lumped-parameter cardiovascular dynamic circuit model equivalent to the pulmonary circulatory system, systemic circulatory system, left cardiac circulatory system, and right cardiac circulatory system; 2. 1. According to the circuit model established in step 1, use the state variable analysis method to analyze the dynamic circuit established, and establish corresponding state equations for relevant nodes in the circuit; 3. According to the needs of simulation, set the corresponding parameters in step 1 and step 2, and According to the circuit model set in step 1 and the state equation set in step 2, solve the state equation to obtain the time curve of each node in the circuit; 4. Calculate the QM obtained in step 3 to obtain the blood return when mitral valve insufficiency flow V RM , mitral valve forward output V FM and mitral valve volume V M .

Description

一种二尖瓣关闭不全血液返流的数字仿真方法A digital simulation method of blood regurgitation in mitral regurgitation

技术领域technical field

本发明涉及心血管系统,尤其是涉及一种二尖瓣关闭不全血液返流的数字仿真方法。The invention relates to a cardiovascular system, in particular to a digital simulation method for mitral regurgitation insufficiency blood backflow.

背景技术Background technique

二尖瓣关闭不全是心血管疾病中常见的病理现象之一,其成因是二尖瓣在心脏收缩期不能正常关闭,血液从左心室流向主动脉的同时有一部分从左心室返流回左心房。二尖瓣关闭不全会产生血液返流,从而引起左心室扩张以及左心室功能障碍,严重时甚至会引发心力衰竭以致死亡。研究二尖瓣关闭不全时的血液返流情况,尤其是不同程度的关闭不全对血液返流的影响,对于二尖瓣临床修复和瓣膜置换手术有着重要的指导意义。Mitral valve insufficiency is one of the common pathological phenomena in cardiovascular diseases. It is caused by the failure of the mitral valve to close normally during systole, and blood flows from the left ventricle to the aorta while part of the blood flows back from the left ventricle to the left atrium. . Mitral valve insufficiency can produce blood regurgitation, which can cause dilation of the left ventricle and dysfunction of the left ventricle, and even lead to heart failure and even death in severe cases. The study of blood regurgitation during mitral valve insufficiency, especially the impact of different degrees of insufficiency on blood regurgitation, has important guiding significance for mitral valve clinical repair and valve replacement surgery.

目前对人体二尖瓣返流情况的分析大都是利用彩色多普勒超声心动图来评估二尖瓣关闭不全的程度,这种方法过多地依赖于医生和操作者的经验,具有一定的主观性(邱峻蔚,孙锟.二尖瓣反流程度影像学评估方法研究进展[J].中国介入影像与治疗学,2010,7(2):203-206),而且该方法仅能测量某个体的实际情况,由于伦理道德的约束,很多实验不能直接在人体身上进行,无法实现不同程度的病变情况,因此无法进一步研究其内在规律。也有采用动物实验方法进行研究,但是由于动物和人存在差异,动物模型实验方法不能完全反映出人体的特征(孙静,二尖瓣反流连续多普勒频谱评估左室松弛时间常数的动物实验研究[D].中国人民解放军军医进修学院,硕士学位论文,2012)。也有学者通过物理仿真的方法,采用机械装置、传感器等建立物理实物模型模拟人体心脏活动状态(闫翾宇,心脏动态建模仿真与模拟装置研究,上海交通大学,硕士学位论文,2011),但建立这种实物模型费时、费力,模型的参数不易调整,建立的模型与实际人体生理特征也存在差异。随着计算机技术的发展,有学者采用数字仿真的方式,即根据血液动力学参数和电路参数之间的等效关系,建立等效的电路模型、数学模型,在计算机上模拟人体心血管系统的运行状态。采用数字仿真方法具有省时、省力、费用低、模型参数便于调整,可以实现极端情况下的实验等优点,便于研究其内在规律。但目前这些方法大都是对人体心血管系统正常情况进行模拟仿真,也有学者对二尖瓣关闭不全情况进行模拟仿真(邓敏,二尖瓣反流的超声成像模拟[D],四川大学,硕士学位论文,2006;张建,二尖瓣偏心反流定量计算的超声模拟研究[D],四川大学,硕士学位论文,2007)。但在这些针对二尖瓣关闭不全的仿真方法中,存在以下不足之处:At present, most of the analysis of human mitral regurgitation is to use color Doppler echocardiography to evaluate the degree of mitral regurgitation. This method relies too much on the experience of doctors and operators, and has a certain degree of subjectivity. (Qiu Junwei, Sun Kun. Research progress in imaging assessment methods for the degree of mitral regurgitation [J]. Chinese Interventional Imaging and Therapeutics, 2010, 7(2):203-206), and this method can only measure a certain individual Due to the constraints of ethics and morality, many experiments cannot be carried out directly on the human body, and different degrees of lesions cannot be achieved, so it is impossible to further study its internal laws. There are also animal experiments for research, but due to differences between animals and humans, animal model experiments cannot fully reflect the characteristics of the human body (Sun Jing, Animal experiments on left ventricular relaxation time constant assessed by continuous Doppler spectrum of mitral valve regurgitation Research [D]. Chinese People's Liberation Army Military Medical Training College, Master's Thesis, 2012). There are also scholars who use mechanical devices, sensors, etc. to establish a physical model to simulate the state of human heart activity through physical simulation (Yan Hongyu, Heart Dynamic Modeling Simulation and Simulation Device Research, Shanghai Jiaotong University, Master's Thesis, 2011), but the establishment of this This kind of physical model is time-consuming and laborious, and the parameters of the model are not easy to adjust. There are also differences between the established model and the actual physiological characteristics of the human body. With the development of computer technology, some scholars adopt digital simulation, that is, according to the equivalent relationship between hemodynamic parameters and circuit parameters, establish equivalent circuit models and mathematical models, and simulate the human cardiovascular system on the computer. Operating status. The digital simulation method has the advantages of saving time, labor, low cost, easy to adjust model parameters, and can realize experiments under extreme conditions, which is convenient for studying its internal laws. However, most of these methods currently simulate the normal conditions of the human cardiovascular system, and some scholars also simulate the conditions of mitral valve insufficiency (Deng Min, Ultrasonic Imaging Simulation of Mitral Regurgitation [D], Sichuan University, Master Dissertation, 2006; Jian Zhang, Ultrasound Simulation Research on Quantitative Calculation of Eccentric Mitral Regurgitation [D], Sichuan University, Master Dissertation, 2007). However, in these simulation methods for mitral regurgitation, there are the following shortcomings:

1)目前的二尖瓣关闭不全仿真方法并没有将肺循环系统、体循环系统和心脏循环系统三个循环系统耦合起来。由于肺循环、体循环、心脏循环系统对二尖瓣返流都会产生影响,因此分析二尖瓣返流时需考虑这三个循环系统的影响。若仅考虑心脏循环系统,对二尖瓣返流的仿真计算将会产生较大误差。1) The current mitral regurgitation simulation method does not couple the three circulatory systems of the pulmonary circulatory system, the systemic circulatory system and the cardiac circulatory system. Since the pulmonary circulation, systemic circulation, and cardiac circulatory system all affect mitral valve regurgitation, the influence of these three circulatory systems should be considered when analyzing mitral valve regurgitation. If only the cardiac circulatory system is considered, the simulation calculation of mitral regurgitation will produce large errors.

2)目前的二尖瓣关闭不全仿真方法不能定量的仿真不同程度二尖瓣关闭不全情况,仅仅能仿真“存在”或者“不存在”二尖瓣关闭不全现象。由于临床上存在不同程度的二尖瓣关闭不全现象,因此对不同程度的二尖瓣关闭不全需要用一个可以连续变化、可以定量表示的方法来进行仿真,才能更加接近实际现象。2) The current mitral regurgitation simulation method cannot quantitatively simulate different degrees of mitral regurgitation, and can only simulate the "existence" or "absence" of mitral regurgitation. Because there are different degrees of mitral valve insufficiency clinically, it is necessary to simulate different degrees of mitral valve insufficiency with a method that can be continuously changed and quantitatively expressed, so as to be closer to the actual phenomenon.

3)目前的二尖瓣关闭不全仿真方法仅仿真了血液返流情况,而不能测量左心室压、左心室容积、左心房压、左心房容积、肺静脉压、二尖瓣流量、二尖瓣容积等相关生理参数的变化。这些生理参数对二尖瓣关闭不全的研究也具有重要意义。3) The current mitral regurgitation simulation method only simulates the blood regurgitation, but cannot measure left ventricular pressure, left ventricular volume, left atrial pressure, left atrial volume, pulmonary venous pressure, mitral valve flow, and mitral valve volume Changes in relevant physiological parameters. These physiological parameters are also of great significance to the study of mitral regurgitation.

发明内容Contents of the invention

本发明的目的在于针对现有二尖瓣关闭不全仿真方法的不足,提供可考虑肺循环系统、体循环系统和心脏循环系统对二尖瓣返流的影响,定量的仿真不同程度二尖瓣关闭不全情况,精确计算血液返流以及其他相关生理参数情况,从而为二尖瓣关闭不全的研究提供帮助的一种二尖瓣关闭不全血液返流的数字仿真方法。The purpose of the present invention is to address the deficiencies of the existing mitral valve insufficiency simulation method, to provide a quantitative simulation of different degrees of mitral regurgitation that can consider the impact of the pulmonary circulatory system, systemic circulatory system and cardiac circulatory system on mitral valve regurgitation , a digital simulation method of blood regurgitation in mitral valve insufficiency by accurately calculating blood regurgitation and other relevant physiological parameters, thereby providing assistance for the study of mitral valve insufficiency.

本发明包括以下步骤:The present invention comprises the following steps:

一、根据血液动力学参数和电路参数之间的等效关系,建立与肺循环系统、体循环系统、左心循环系统、右心循环系统等效的四腔室集总参数心血管动态电路模型;1. According to the equivalent relationship between hemodynamic parameters and circuit parameters, establish a four-chamber lumped parameter cardiovascular dynamic circuit model equivalent to the pulmonary circulation system, systemic circulation system, left cardiac circulation system, and right cardiac circulation system;

在步骤一中,In step one,

所述与左心循环系统等效的电路模块MLH由以下方式构成:电阻RM一端接于PLA节点,电阻RM另一端与二极管DM正极串联,二极管DM负极接于PLV节点;PLA节点、PLV节点分别通过时变倒电容ELA(t)与ELV(t)接地;The circuit module M LH equivalent to the left heart circulatory system is composed of the following method: one end of the resistance R M is connected to the P LA node, the other end of the resistance R M is connected in series with the anode of the diode D M , and the cathode of the diode D M is connected to the P LV node ; The P LA node and the P LV node are respectively grounded through the time-varying inverted capacitance E LA (t) and E LV (t);

所述与体循环系统等效的电路模块MT由以下方式构成:电阻RAP的一端接于PAP节点,电阻RAP的另一端与电感LAP串联,电感LAP的另一端与电阻RAD连接于PAD节点,电阻RAD的另一端连接于PVC节点;电路中PAP节点、PAD节点、PPV节点这三点分别通过电容CAP、CAD、CPVC接地;The circuit module MT equivalent to the body circulatory system is formed in the following manner: one end of the resistance R AP is connected to the P AP node, the other end of the resistance R AP is connected in series with the inductor L AP , the other end of the inductor L AP is connected to the resistance R AD Connected to the P AD node, the other end of the resistor R AD is connected to the P VC node; the P AP node, P AD node, and P PV node in the circuit are grounded through the capacitors C AP , C AD , and C PVC respectively;

所述与肺循环系统等效的电路模块MF由以下方式构成:电阻RPA的一端接于PPA节点,电阻RPA的另一端与电感LPA串联,电感LPA的另一端与电阻RPP连接于PPP节点,电阻RPP的另一端连接于PPV节点;电路中PPA节点、PPP节点、PPV节点这三点分别通过电容CPA、CPP、CPV接地;The circuit module M F equivalent to the pulmonary circulation system is composed of the following method: one end of the resistance R PA is connected to the P PA node, the other end of the resistance R PA is connected in series with the inductance L PA , and the other end of the inductance L PA is connected to the resistance R PP Connected to the P PP node, the other end of the resistor R PP is connected to the PP PV node; the three points of the P PA node, P PP node, and PP PV node in the circuit are grounded through the capacitors C PA , C PP , and C PV respectively;

所述与右心循环系统等效的电路模块MRH由以下方式构成:电阻RT一端接于PRA节点,电阻RT另一端与二极管DT正极串联,二极管DT负极接于PRV节点;PRA节点、PRV节点分别通过时变倒电容ERA(t)与ERV(t)接地;The circuit module M RH equivalent to the right heart circulatory system is composed of the following method: one end of the resistor RT is connected to the P RA node, the other end of the resistor RT is connected in series with the anode of the diode DT , and the cathode of the diode DT is connected to the P RV node ; The P RA node and the P RV node are respectively grounded through the time-varying reverse capacitance E RA (t) and E RV (t);

所述电路模块MLH接电阻RA一端,电阻RA另一端与二极管DA正极串联,二极管DA负极和电路模块MT相连;电阻RVC一端接于电路模块MT,电阻RVC另一端接于电路模块MRH;电路模块MRH接电阻RPT一端,电阻RPT另一端与二极管DPT正极串联,二极管DPT负极和电路模块MF相连;电路模块MF接电阻RPV一端,电阻RPV另一端接电路模块MLHThe circuit module MLH is connected to one end of the resistor RA , the other end of the resistor RA is connected in series with the anode of the diode DA , and the cathode of the diode DA is connected to the circuit module MT ; one end of the resistor R VC is connected to the circuit module MT, and the other end of the resistor R VC is connected to the circuit module MT . One end is connected to the circuit module M RH ; the circuit module M RH is connected to one end of the resistor R PT , the other end of the resistor R PT is connected in series with the anode of the diode D PT , and the cathode of the diode D PT is connected to the circuit module M F ; the circuit module M F is connected to one end of the resistor R PV , the other end of the resistor R PV is connected to the circuit module M LH ;

电路中各个元器件的含义以及表示的仿真生理意义如表1所示;The meaning of each component in the circuit and the simulated physiological significance of the representation are shown in Table 1;

表1Table 1

符号symbol 仿真生理意义Simulation of physiological meaning 实际物理元件actual physical components RM R M 二尖瓣特征阻抗mitral valve characteristic impedance 电阻resistance RA R A 主动脉瓣特征阻抗Aortic valve characteristic impedance 电阻resistance RT R T 三尖瓣特征阻抗tricuspid characteristic impedance 电阻resistance RPT R PT 肺动脉瓣特征阻抗Pulmonary Valve Characteristic Impedance 电阻resistance RAP R AP 主动脉近心端特征阻抗proximal aortic characteristic impedance 电阻resistance CAP C AP 主动脉近心端血流顺应性proximal aortic blood flow compliance 电容capacitance LAP L AP 主动脉近心端血流惯性proximal aortic flow inertia 电感inductance RAD R AD 主动脉远心端特征阻抗Distal Aortic Characteristic Impedance 电阻resistance CAD C AD 主动脉远心端血流顺应性blood flow compliance at the distal end of the aorta 电容capacitance RVC R VC 腔静脉特征阻抗characteristic impedance of vena cava 电阻resistance CVC C VC 腔静脉血流惯性vena cava flow inertia 电容capacitance RPA RPA 肺动脉近心端特征阻抗Pulmonary artery proximal characteristic impedance 电阻resistance CPA C PA 肺动脉近心端血流顺应性Pulmonary artery proximal blood flow compliance 电容capacitance LPA L PA 肺动脉近心端血流惯性Pulmonary Artery Proximal Flow Inertia 电感inductance RPP R PP 肺动脉远心端特征阻抗characteristic impedance of distal pulmonary artery 电阻resistance CPP C PP 肺动脉远心端血流顺应性blood flow compliance at the distal end of the pulmonary artery 电容capacitance RPV R PV 肺静脉特征阻抗Pulmonary vein characteristic impedance 电阻resistance CPV C PV 肺静脉血流惯性Inertia of pulmonary vein flow 电容capacitance ERV(t)E RV (t) 右心室时变弹性函数Right ventricular time-varying elasticity function 时变倒电容time-varying inverting capacitance ERA(t)E RA (t) 右心房时变弹性函数Right atrial time-varying elastic function 时变倒电容time-varying inverting capacitance ELV(t)E LV (t) 左心室时变弹性函数left ventricular time-varying elasticity function 时变倒电容time-varying inverting capacitance ELA(t)E LA (t) 左心房时变弹性函数left atrial time-varying elastic function 时变倒电容time-varying inverting capacitance DA D A 主动脉瓣开关状态aortic valve status 二极管diode DT D T 三尖瓣开关状态tricuspid valve state 二极管diode DPT PT 肺动脉瓣开关状态Pulmonary valve switch status 二极管diode DM D M 二尖瓣关闭不全程度degree of mitral regurgitation 二极管diode

电路中的ERV(t)、ERA(t)、ELV(t)、ELA(t)时变倒电容分别用以下时变弹性函数表示:The E RV (t), E RA (t), E LV (t), E LA (t) time-varying reciprocal capacitances in the circuit are represented by the following time-varying elastic functions:

(1)ELA(t)处的时变弹性函数为:(1) The time-varying elastic function at E LA (t) is:

ELA(t)=EminLA+(EmaxLA-EminLA)×En(t)E LA (t)=E minLA +(E maxLA -E minLA )×En(t)

其中:in:

EmaxLA表示左心房时变弹性函数最大取值,E maxLA represents the maximum value of the time-varying elastic function of the left atrium,

EminLA表示左心房时变弹性函数最小取值,E minLA represents the minimum value of the time-varying elastic function of the left atrium,

En(t)用如下公式表示:En(t) is expressed by the following formula:

Figure BDA00003626458000041
Figure BDA00003626458000041

其中:t表示时间变量,T表示心动周期,Tac表示心房收缩开始时间、Tacp表示心房收缩持续时间,Tar表示心房舒张开始时间、Tarp表示心房主动舒张持续时间;Where: t represents the time variable, T represents the cardiac cycle, T ac represents the start time of atrial contraction, T acp represents the duration of atrial contraction, T ar represents the start time of atrial diastole, and T arp represents the duration of atrial active relaxation;

(2)ERA(t)处的时变弹性函数为:(2) The time-varying elastic function at E RA (t) is:

ERA(t)=EminRA+(EmaxRA-EminRA)×En(t)E RA (t)=E minRA +(E maxRA -E minRA )×En(t)

其中:in:

EmaxRA表示右心房时变弹性函数最大取值,E maxRA represents the maximum value of the time-varying elastic function of the right atrium,

EminRA表示右心房时变弹性函数最小取值,E minRA represents the minimum value of the time-varying elastic function of the right atrium,

En(t)的表示方法同上所示,即用式(1)表示;The expression method of En(t) is the same as that shown above, that is, expressed by formula (1);

(3)ERV(t)处的时变弹性函数为:(3) The time-varying elastic function at E RV (t) is:

ERV(t)=EminRV+(EmaxRV-EminRV)×En(t)E RV (t)=E minRV +(E maxRV -E minRV )×En(t)

其中:in:

EmaxRV表示右心室时变弹性函数最大取值,E maxRV represents the maximum value of the time-varying elastic function of the right ventricle,

EminRV表示右心室时变弹性函数最小取值,E minRV represents the minimum value of the time-varying elastic function of the right ventricle,

En(t)用如下公式表示:En(t) is expressed by the following formula:

其中:in:

Figure BDA00003626458000051
t表示时间变量,T表示心动周期,Td表示心室收缩时间;
Figure BDA00003626458000051
t represents the time variable, T represents the cardiac cycle, and T d represents the ventricular systole time;

(4)ELV(t)处的时变弹性函数为:(4) The time-varying elastic function at E LV (t) is:

ELV(t)=EminLV+(EmaxLV-EminLV)×En(t)E LV (t)=E minLV +(E maxLV -E minLV )×En(t)

其中:in:

EmaxLV表示左心室时变弹性函数最大取值,E maxLV represents the maximum value of the time-varying elastic function of the left ventricle,

EminLV表示左心室时变弹性函数最小取值,E minLV represents the minimum value of the time-varying elastic function of the left ventricle,

En(t)的表示方法同上所示,即用式(2)表示;The expression method of En(t) is the same as that shown above, that is, expressed by formula (2);

(5)电路中DM的取值为:(5) The value of D M in the circuit is:

DD. Mm == 11 ,, &Delta;P&Delta;P &GreaterEqual;&Greater Equal; 00 00 ~~ 11 ,, &Delta;P&Delta;P << 00

ΔP表示为PLA与PLV处的电压差,ΔP is expressed as the voltage difference between P LA and PL LV ,

当ΔP<0时,0≤DM<1,DM表示二尖瓣关闭不全程度,是一个可以连续变化、可以定量表示参数,当DM等于0时表示不存在二尖瓣关闭不全病变的正常生理状态,DM的值越大表示二尖瓣关闭不全程度越严重。When ΔP<0, 0≤D M <1, D M represents the degree of mitral regurgitation, which is a parameter that can be continuously changed and can be expressed quantitatively. When D M is equal to 0, it means that there is no mitral regurgitation. In normal physiological state, the larger the value of D M is, the more serious the degree of mitral valve insufficiency is.

二、根据步骤一建立的电路模型,用状态变量分析法分析建立的动态电路,对电路中相关节点按照以下公式建立相应的状态方程;2. According to the circuit model established in step 1, analyze the dynamic circuit established by the state variable analysis method, and establish corresponding state equations for relevant nodes in the circuit according to the following formula;

(( PP LVLV -- PP APAP )) DD. AA // RR AA == QQ APAP ++ CC APAP dd PP APAP dtdt

PP APAP -- PP ADAD == LL APAP dd QQ APAP dtdt ++ QQ APAP RR APAP

QQ APAP == (( PP ADAD -- PP VCVC )) // RR ADAD ++ CC ADAD dd PP ADAD dtdt

(( PP ADAD -- PP VCVC )) // RR ADAD == CC VCVC dd PP VCVC dtdt ++ PP VCVC -- PP RARA RR VCVC

(( PP RVRV -- PP PAPA )) DD. PTPT // RR PTPT == CC PAPA dd PP PAPA dtdt ++ QQ PAPA

PP PAPA -- PP PPPP == QQ PAPA RR PAPA ++ LL PAPA dd QQ PAPA dtdt

QQ PAPA == CC PPPP dd PP PPPP dtdt ++ (( PP PPPP -- PP PVPV )) // RR PPPP

(( PP PPPP -- PP PVPV )) // RR PPPP == CC PVPV dd PP PVPV dtdt ++ (( PP PVPV -- PP LALA )) // RR PVPV ;;

三、根据仿真的需求,设置步骤一、步骤二中的相应参数,并根据步骤一设置的电路模型以及步骤二设置的状态方程,进行求解状态方程得到电路中个结点时间曲线图;所需设置的参数及其表示的含义如表2所示,电路中个结点的时间曲线图表示含义如表3所示。3. According to the needs of the simulation, set the corresponding parameters in step 1 and step 2, and solve the state equation according to the circuit model set in step 1 and the state equation set in step 2 to obtain the time curve of each node in the circuit; The set parameters and their meanings are shown in Table 2, and the meanings of the time curves of each node in the circuit are shown in Table 3.

表2Table 2

符号symbol 仿真生理意义Simulation of physiological meaning RM R M 二尖瓣特征阻抗mitral valve characteristic impedance RA R A 主动脉瓣特征阻抗Aortic valve characteristic impedance RT R T 三尖瓣特征阻抗tricuspid characteristic impedance RPT R PT 肺动脉瓣特征阻抗Pulmonary Valve Characteristic Impedance RAP R AP 主动脉近心端特征阻抗proximal aortic characteristic impedance CAP C AP 主动脉近心端血流顺应性proximal aortic blood flow compliance LAP L AP 主动脉近心端血流惯性proximal aortic flow inertia RAD R AD 主动脉远心端特征阻抗Distal Aortic Characteristic Impedance CAD C AD 主动脉远心端血流顺应性blood flow compliance at the distal end of the aorta RVC R VC 腔静脉特征阻抗characteristic impedance of vena cava CVC C VC 腔静脉血流惯性gInertia of vena cava flow g RPA RPA 肺动脉近心端特征阻抗Pulmonary artery proximal characteristic impedance CPA C PA 肺动脉近心端血流顺应性Pulmonary artery proximal blood flow compliance LPA L PA 肺动脉近心端血流惯性Pulmonary Artery Proximal Flow Inertia RPP R PP 肺动脉远心端特征阻抗characteristic impedance of distal pulmonary artery CPP C PP 肺动脉远心端血流顺应性blood flow compliance at the distal end of the pulmonary artery RPV R PV 肺静脉特征阻抗Pulmonary vein characteristic impedance CPV C PV 肺静脉血流惯性gPulmonary vein flow inertia g TT 心动周期Cardiac cycle Td T d 心室收缩时间ventricular systolic time Tac Tac 心房收缩开始时间atrial systole onset time Tacp T acp 心房收缩持续时间atrial contraction duration Tar Tar 心房舒张开始时间atrial diastolic onset time Tarp T arp 心房主动舒张持续时间duration of active atrial relaxation EminLA E minLA 左心室时变弹性函数最小取值The minimum value of time-varying elastic function of left ventricle EmaxLA E max LA 左心室时变弹性函数最大取值The maximum value of time-varying elastic function of left ventricle EminRA E minRA 右心室时变弹性函数最小取值The minimum value of time-varying elastic function of right ventricle EmaxRA E maxRA 右心室时变弹性函数最大取值The maximum value of time-varying elastic function of right ventricle EminLV E minLV 左心房时变弹性函数最小取值The minimum value of time-varying elastic function of left atrium EmaxLV E maxLV 左心房时变弹性函数最大取值The maximum value of time-varying elastic function of left atrium EminRV E minRV 右心房时变弹性函数最小取值The minimum value of time-varying elastic function of right atrium EmaxRV E maxRV 右心房时变弹性函数最大取值The maximum value of time-varying elastic function of right atrium DM D M 二尖瓣关闭不全程度degree of mitral regurgitation

表3table 3

结点符号node symbol 仿真生理意义Simulation of physiological meaning PLV P LV 左心室压left ventricular pressure PLA PLA 左心房压left atrial pressure PAP P AP 主动脉压Aortic pressure VLV V LV 左心房容积left atrial volume VLA V LA 左心室容积left ventricular volume PPV P PV 肺静脉压pulmonary venous pressure QM Q M 二尖瓣流量mitral valve flow

四、对步骤三得到的QM按照如下公式进行计算,得到二尖瓣关闭不全时血液返流量VRM、二尖瓣前向输出量VFM以及二尖瓣容积VM4. Calculate the Q M obtained in step 3 according to the following formula to obtain the blood regurgitation volume V RM , the mitral valve forward output volume V FM and the mitral valve volume V M when the mitral valve is insufficient,

VV RMRM == -- &Integral;&Integral; TT 00 ++ TT dd TT 00 ++ TT QQ Mm (( tt )) dtdt ,, TT 00 ++ TT dd &le;&le; tt &le;&le; TT 00 ++ TT

VV FMFM == &Integral;&Integral; TT 00 TT 00 ++ TT dd QQ Mm (( tt )) dtdt ,, TT 00 &le;&le; tt &le;&le; TT 00 ++ TT dd

VV Mm == &Integral;&Integral; TT 00 TT 00 ++ TT QQ Mm (( tt )) dtdt ,, TT 00 &le;&le; tt &le;&le; TT 00 ++ TT

式中T0表示任一心动周期的开始时间,T表示心动周期。In the formula, T 0 represents the start time of any cardiac cycle, and T represents the cardiac cycle.

本发明提出的一种二尖瓣关闭不全血液返流的数字仿真方法,替代实物物理模型,可以动态实时观察仿真结果,这种方法缩短实验时间,降低费用,增强实验的灵活性和安全性,能够模拟一些在人体、动物以及实物物理模型上无法产生的现象。本发明提出的二尖瓣关闭不全血液返流的数字仿真方法克服了现有方法的不足之处,结合了肺循环系统、体循环系统和心脏循环系统三个系统,可以连续变化、定量表示二尖瓣关闭不全程度,可以精确计算血液返流以及其他相关生理参数情况,对临床研究二尖瓣关闭不全具有重要指导意义。A digital simulation method of mitral valve insufficiency blood regurgitation proposed by the present invention replaces the physical model and can observe the simulation results dynamically and in real time. This method shortens the experimental time, reduces the cost, and enhances the flexibility and safety of the experiment. It can simulate some phenomena that cannot be produced on the human body, animals and physical models. The digital simulation method of mitral valve insufficiency blood regurgitation proposed by the present invention overcomes the shortcomings of the existing methods, and combines the three systems of the pulmonary circulation system, the systemic circulation system and the cardiac circulation system, and can continuously change and quantitatively represent the mitral valve The degree of regurgitation can accurately calculate blood regurgitation and other related physiological parameters, which has important guiding significance for clinical research on mitral regurgitation.

附图说明Description of drawings

图1为本发明实施例的包含肺循环系统、体循环系统和心脏循环系统的四腔室集总参数心血管电路模型。FIG. 1 is a four-chamber lumped-parameter cardiovascular circuit model including a pulmonary circulatory system, a systemic circulatory system and a cardiac circulatory system according to an embodiment of the present invention.

图2为左心室压时间曲线仿真结果图。Fig. 2 is a graph showing the simulation results of the left ventricular pressure time curve.

图3为左心室容积时间曲线仿真结果图。Fig. 3 is a graph showing the simulation results of the volume-time curve of the left ventricle.

图4为左心房压时间曲线仿真结果图。Fig. 4 is a simulation result diagram of the left atrial pressure time curve.

图5为左心房容积时间曲线仿真结果图。Fig. 5 is a graph showing the simulation results of the volume-time curve of the left atrium.

图6为肺静脉压时间曲线仿真结果图。Fig. 6 is a simulation result diagram of the time curve of pulmonary venous pressure.

图7为二尖瓣流量时间曲线仿真结果图。Fig. 7 is a graph showing the simulation results of the flow time curve of the mitral valve.

图8为二尖瓣容积时间曲线仿真结果图。Fig. 8 is a graph showing the simulation results of the volume-time curve of the mitral valve.

具体实施方式Detailed ways

以下实施例将结合附图对本发明做进一步说明。The following embodiments will further illustrate the present invention in conjunction with the accompanying drawings.

本发明实施例的具体步骤如下:The concrete steps of the embodiment of the present invention are as follows:

步骤一、step one,

按照图1建立四腔室集总参数心血管动态电路模型,电路中各个元器件的含义以及表示的仿真生理意义如表1所示。According to Figure 1, a four-chamber lumped parameter cardiovascular dynamic circuit model was established. The meaning of each component in the circuit and the simulated physiological significance expressed are shown in Table 1.

步骤二、Step two,

根据步骤一建立的电路模型,用状态变量分析法分析建立的动态电路,对电路中相关节点按照说明书中公式建立相应的状态方程。According to the circuit model established in step 1, the established dynamic circuit is analyzed by the state variable analysis method, and the corresponding state equations are established for the relevant nodes in the circuit according to the formula in the specification.

步骤三、设置相应参数(详见表4)并求解状态方程,其中DM的值按照如下公式,表示仿真中度二尖瓣关闭不全情况。Step 3: Set the corresponding parameters (see Table 4 for details) and solve the state equation, wherein the value of D M represents the simulated moderate mitral regurgitation according to the following formula.

DD. Mm == 11 ,, &Delta;P&Delta;P &GreaterEqual;&Greater Equal; 00 0.010.01 ,, &Delta;P&Delta;P << 00

表4Table 4

参数parameter 取值value RM R M 0.007mmHg*s/ml0.007mmHg*s/ml RA R A 0.01mmHg*s/ml0.01mmHg*s/ml RT R T 0.007mmHg*s/ml0.007mmHg*s/ml RPT R PT 0.01mmHg*s/ml0.01mmHg*s/ml RAP R AP 0.230mmHg*s/ml0.230mmHg*s/ml CAP C AP 1.800ml/mmHg1.800ml/mmHg LAP L AP 0.014mmHg*s2/ml0.014mmHg*s2/ml RAD R AD 1.000mmHg*s/ml1.000mmHg*s/ml CAD C AD 0.140ml/mmHg0.140ml/mmHg RVC R VC 0.0368mmHg*s/ml0.0368mmHg*s/ml CVC C VC 2.5181ml/mmHg2.5181ml/mmHg RPA R PA 0.023mmHg*s/ml0.023mmHg*s/ml CPA C PA 5.000ml/mmHg5.000ml/mmHg LPA L PA 0.0018mmHg*s2/ml0.0018mmHg*s2/ml RPP R PP 0.100mmHg*s/ml0.100mmHg*s/ml CPP C PP 5.800ml/mmHg5.800ml/mmHg RPV R PV 0.0056mmHg*s/ml0.0056mmHg*s/ml CPV C PV 25.00ml/mmHg25.00ml/mmHg EminLA E minLA 0.15mmHg/ml0.15mmHg/ml EmaxLA E max LA 0.25mmHg/ml0.25mmHg/ml EminRA E minRA 0.15mmHg/ml0.15mmHg/ml EmaxRA E maxRA 0.25mmHg/ml0.25mmHg/ml EminLV E minLV 0.06mmHg/ml0.06mmHg/ml EmaxLV E maxLV 3mmHg/ml3mmHg/ml EminRV E minRV 0.06mmHg/ml0.06mmHg/ml EmaxRV E maxRV 1mmHg/ml1mmHg/ml TT 0.80.8 Tac Tac 0.690.69 Tacp T acp 0.100.10 Tar Tar 0.790.79 Tarp T arp 0.100.10

采用四阶龙格库塔法对状态方程的求解。得到主要状态变量(PLV、VLV、PLA、VLA、PPV)的时间曲线图,如图2~6。The equation of state is solved using the fourth-order Runge-Kutta method. Obtain the time curves of the main state variables (P LV , V LV , P LA , V LA , P PV ), as shown in Figures 2-6.

步骤四、对步骤三得到的QM按照如说明书中的公式行计算,得到二尖瓣关闭不全时血液返流量VRM、二尖瓣前向输出量VFM以及二尖瓣容积VMStep 4: Calculate the Q M obtained in Step 3 according to the formula in the instruction manual, and obtain the blood regurgitation volume V RM , the mitral valve forward output volume V FM and the mitral valve volume V M during mitral regurgitation.

结果如图7和8。The results are shown in Figures 7 and 8.

最后所应说明的是,以上实施例仅用以说明本发明专利技术方案而非限制,尽管参照较佳实施例对本发明进行了说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者同等替换,而不脱离本发明方案的精神和范围。Finally, it should be noted that the above examples are only used to illustrate the patented technical solution of the present invention without limitation, although the present invention has been described with reference to the preferred embodiments, those of ordinary skill in the art should understand that the technical solution of the present invention can be Modifications or equivalent replacements can be made without departing from the spirit and scope of the solutions of the present invention.

Claims (8)

1. the digital simulation method of a mitral valve insufficiency blood reflux is characterized in that may further comprise the steps:
One, according to the equivalent relation between hemodynamic parameter and the circuit parameter, the cardiovascular dynamic circuit model of four chamber lumped parameters of foundation and systemic pulmonary circulation, systemic circulatory system, left heart circulation system, the equivalence of right heart circulation system;
Two, the circuit model of setting up according to step 1 with the dynamic circuit that the State-Variable Analysis Method analysis is set up, is set up corresponding state equation to interdependent node in the circuit;
Three, according to the demand of emulation, the relevant parameter in setting steps one, the step 2, and the state equation that arranges of the circuit model that arranges according to step 1 and step 2 carry out the solving state equation and obtain a node time curve map in the circuit;
Four, the Q that step 3 is obtained MCalculate blood reflux amount V when obtaining mitral valve insufficiency RM, bicuspid valve forward direction output quantity V FMAnd bicuspid valve volume V M
2. a kind of digital simulation method of mitral valve insufficiency blood reflux as claimed in claim 1 is characterized in that in step 1, the circuit module M of described and the equivalence of left heart circulation system LHConsisted of by following mode: resistance R MOne is terminated at P LANode, resistance R MThe other end and diode D MAnodal series connection, diode D MNegative pole is connected to P LVNode; P LANode, P LVNode respectively by the time become elastance E LA(t) and E LV(t) ground connection.
3. a kind of digital simulation method of mitral valve insufficiency blood reflux as claimed in claim 1 is characterized in that in step 1, the circuit module M of described and systemic circulatory system equivalence TConsisted of by following mode: resistance R APOne be terminated at P APNode, resistance R APThe other end and inductance L APSeries connection, inductance L APThe other end and resistance R ADBe connected in P ADNode, resistance R ADThe other end be connected in P VCNode; P in the circuit APNode, P ADNode, P PVThese 3 of nodes pass through respectively capacitor C AP, C AD, C PVCGround connection.
4. a kind of digital simulation method of mitral valve insufficiency blood reflux as claimed in claim 1 is characterized in that in step 1, the circuit module M of described and systemic pulmonary circulation equivalence FConsisted of by following mode: resistance R PAOne be terminated at P PANode, resistance R PAThe other end and inductance L PASeries connection, inductance L PAThe other end and resistance R PPBe connected in P PPNode, resistance R PPThe other end be connected in P PVNode; P in the circuit PANode, P PPNode, P PVThese 3 of nodes pass through respectively capacitor C PA, C PP, C PVGround connection.
5. a kind of digital simulation method of mitral valve insufficiency blood reflux as claimed in claim 1 is characterized in that in step 1, the circuit module M of described and the equivalence of right heart circulation system RHConsisted of by following mode: resistance R TOne is terminated at P RANode, resistance R TThe other end and diode D TAnodal series connection, diode D TNegative pole is connected to P RVNode; P RANode, P RVNode respectively by the time become elastance E RA(t) and E RV(t) ground connection.
6. a kind of digital simulation method of mitral valve insufficiency blood reflux as claimed in claim 1 is characterized in that in step 1 described circuit module M LHConnecting resistance R AOne end, resistance R AThe other end and diode D AAnodal series connection, diode D ANegative pole and circuit module M TLink to each other; Resistance R VCOne is terminated at circuit module M T, resistance R VCThe other end is connected to circuit module M RHCircuit module M RHConnecting resistance R PTOne end, resistance R PTThe other end and diode D PTAnodal series connection, diode D PTNegative pole and circuit module M FLink to each other; Circuit module M FConnecting resistance R PVOne end, resistance R PVOther end connection circuit module M LH
E in the circuit RV(t), E RA(t), E LV(t), E LA(t) become the time elastance respectively when following the change Elastic Function represent:
(1) E LA(t) locate the time become Elastic Function into:
E LA(t)=E minLA+(E maxLA-E minLA)×En(t)
Wherein:
E MaxLABecome the Elastic Function maximum occurrences during expression atrium sinistrum,
E MinLABecome the minimum value of Elastic Function during the expression atrium sinistrum,
En (t) represents with following formula:
Figure FDA00003626457900021
Wherein: t represents time variable, and T represents cardiac cycle, T AcExpression atrial contraction start time, T AcpThe expression atrial contraction duration, T ArExpression auricular diastole start time, T ArpThe expression atrium Active Diastolic duration;
(2) E RA(t) locate the time become Elastic Function into:
E RA(t)=E minRA+(E maxRA-E minRA)×En(t)
Wherein:
E MaxRABecome the Elastic Function maximum occurrences during expression atrium dextrum,
E MinRABecome the minimum value of Elastic Function during the expression atrium dextrum,
Shown in the method for expressing of En (t) is the same, namely use formula (1) expression;
(3) E RV(t) locate the time become Elastic Function into:
E RV(t)=E minRV+(E maxRV-E minRV)×En(t)
Wherein:
E MaxRVBecome the Elastic Function maximum occurrences during expression right ventricle,
E MinRVBecome the minimum value of Elastic Function during the expression right ventricle,
En (t) represents with following formula:
Figure FDA00003626457900031
Wherein:
Figure FDA00003626457900032
T represents time variable, and T represents cardiac cycle, T dThe expression ventricular systole time;
(4) E LV(t) locate the time become Elastic Function into:
E LV(t)=E minLV+(E maxLV-E minLV)×En(t)
Wherein:
E MaxLVBecome the Elastic Function maximum occurrences during expression left ventricle,
E MinLVBecome the minimum value of Elastic Function during the expression left ventricle,
Shown in the method for expressing of En (t) is the same, namely use formula (2) expression;
(5) D in the circuit MValue be:
D M = 1 , &Delta;P &GreaterEqual; 0 0 ~ 1 , &Delta;P < 0
Δ P is expressed as P LAWith P LVThe voltage difference at place,
When Δ P<0,0≤D M<1, D MExpression mitral valve insufficiency degree, be one can change continuously, can the quantificational expression parameter, work as D MEqual to represent not exist the normal physiological state of mitral valve insufficiency pathology at 0 o'clock, D MThe larger expression mitral valve insufficiency of value degree more serious.
7. a kind of digital simulation method of mitral valve insufficiency blood reflux as claimed in claim 1 is characterized in that in step 2, and the corresponding state equation of described foundation can be according to following Formula:
( P LV - P AP ) D A / R A = Q AP + C AP d P AP dt
P AP - P AD = L AP d Q AP dt + Q AP R AP
Q AP = ( P AD - P VC ) / R AD + C AD d P AD dt
( P AD - P VC ) / R AD = C VC d P VC dt + P VC - P RA R VC
( P RV - P PA ) D PT / R PT = C PA d P PA dt + Q PA
P PA - P PP = Q PA R PA + L PA d Q PA dt
Q PA = C PP d P PP dt + ( P PP - P PV ) / R PP
( P PP - P PV ) / R PP = C PV d P PV dt + ( P PV - P LA ) / R PV .
8. a kind of digital simulation method of mitral valve insufficiency blood reflux as claimed in claim 1 is characterized in that in step 4 the described Q that step 3 is obtained MCalculate, can calculate according to following formula:
V RM = - &Integral; T 0 + T d T 0 + T Q M ( t ) dt , T 0 + T d &le; t &le; T 0 + T
V FM = &Integral; T 0 T 0 + T d Q M ( t ) dt , T 0 &le; t &le; T 0 + T d
V M = &Integral; T 0 T 0 + T Q M ( t ) dt , T 0 &le; t &le; T 0 + T
T in the formula 0Represent the start time of arbitrary cardiac cycle, T represents cardiac cycle.
CN201310338575.XA 2013-08-06 2013-08-06 A kind of digital simulation method of mitral valve insufficiency blood reflux Expired - Fee Related CN103366072B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310338575.XA CN103366072B (en) 2013-08-06 2013-08-06 A kind of digital simulation method of mitral valve insufficiency blood reflux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310338575.XA CN103366072B (en) 2013-08-06 2013-08-06 A kind of digital simulation method of mitral valve insufficiency blood reflux

Publications (2)

Publication Number Publication Date
CN103366072A true CN103366072A (en) 2013-10-23
CN103366072B CN103366072B (en) 2016-04-06

Family

ID=49367403

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310338575.XA Expired - Fee Related CN103366072B (en) 2013-08-06 2013-08-06 A kind of digital simulation method of mitral valve insufficiency blood reflux

Country Status (1)

Country Link
CN (1) CN103366072B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104794973A (en) * 2015-04-29 2015-07-22 中国人民解放军第四军医大学 Distributed-type cardiovascular system simulation model
CN109844869A (en) * 2016-09-23 2019-06-04 皇家飞利浦有限公司 System and method for assessing the outflow obstruction of the heart of object
CN114913752A (en) * 2022-05-26 2022-08-16 中国人民解放军陆军军医大学 A Human Respiratory System Model Based on Lumped Parameters

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4009306A4 (en) * 2019-08-02 2023-01-25 Fasotec Co., Ltd. Mitral valve model and fixing jig

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100210899A1 (en) * 2009-01-21 2010-08-19 Tendyne Medical, Inc. Method for percutaneous lateral access to the left ventricle for treatment of mitral insufficiency by papillary muscle alignment
CN102440811A (en) * 2010-09-14 2012-05-09 西门子公司 Apparatus and method for minimally invasive therapy of mitral regurgitation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100210899A1 (en) * 2009-01-21 2010-08-19 Tendyne Medical, Inc. Method for percutaneous lateral access to the left ventricle for treatment of mitral insufficiency by papillary muscle alignment
CN102440811A (en) * 2010-09-14 2012-05-09 西门子公司 Apparatus and method for minimally invasive therapy of mitral regurgitation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
冯敏 等: "基于双弹性腔的左心循环系统的建模与仿真", 《厦门大学学报(自然科学版)》 *
胡喆 等: "心脏—肺循环—体循环系统建模初探", 《同济大学学报》 *
郑莉: "心血管系统的电路建模及电磁生物效应研究", 《中国优秀硕士学位论文全文数据库-医药卫生科技辑》 *
陈丽琳 等: "心血管循环系统的建模仿真", 《北京生物医学工程》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104794973A (en) * 2015-04-29 2015-07-22 中国人民解放军第四军医大学 Distributed-type cardiovascular system simulation model
CN109844869A (en) * 2016-09-23 2019-06-04 皇家飞利浦有限公司 System and method for assessing the outflow obstruction of the heart of object
CN109844869B (en) * 2016-09-23 2024-05-14 皇家飞利浦有限公司 System and method for assessing outflow obstruction of a heart of a subject
CN114913752A (en) * 2022-05-26 2022-08-16 中国人民解放军陆军军医大学 A Human Respiratory System Model Based on Lumped Parameters
CN114913752B (en) * 2022-05-26 2024-03-26 中国人民解放军陆军军医大学 Human respiratory system model based on lumped parameters

Also Published As

Publication number Publication date
CN103366072B (en) 2016-04-06

Similar Documents

Publication Publication Date Title
JP2016513516A (en) Systems and methods for individual hemodynamic modeling and monitoring
CN104244813B (en) The framework of the personalization that coronary flow is calculated during for tranquillization and hyperemia
Ferreira et al. A nonlinear state-space model of a combined cardiovascular system and a rotary pump
Kolyva et al. A mock circulatory system with physiological distribution of terminal resistance and compliance: application for testing the intra‐aortic balloon pump
CN212342143U (en) heart bionic device
CN103366072B (en) A kind of digital simulation method of mitral valve insufficiency blood reflux
CN111241759B (en) FFR (Fabry-Perot) rapid calculation method based on zero-dimensional hemodynamic model
Sooriamoorthy et al. A Study on the Effect of Electrical Parameters of Zero-Dimensional Cardiovascular System on Aortic Waveform
CN104068841B (en) A kind of measuring method and device measuring Indices of Systolic Time parameter
CN205981729U (en) A simulation cavity room for external simulation blood circulation
CN104050857B (en) cardiovascular system simulation model based on lumped parameter
Fanni et al. An integrated in-vitro and in-silico workflow to study the pulmonary bifurcation hemodynamics
US20240278001A1 (en) Systems and methods for simulating cardiovascular fluid flow
Rezaienia et al. In-vitro investigation of cerebral-perfusion effects of a rotary blood pump installed in the descending aorta
CN115736874B (en) Simulation method for predicting personalized in-vitro counterpulsation hemodynamic effect
CN115019613A (en) A Human Cardiovascular System Based on Lumped Parameters and Its Modeling Method and Application
Siewnicka et al. Hybrid cardiovascular simulator as a tool for physical reproduction of the conditions prevailing in the apex of the heart
CN115050255A (en) Cardiovascular fluid dynamics simulation test system
Huang et al. Modeling left ventricular dynamics using a switched system approach based on a modified atrioventricular piston unit
Manoliu Modeling cardiovascular hemodynamics in a model with nonlinear parameters
Pironet Model-based prediction of the response to vascular filling therapy
CN116884622A (en) A method and system for intelligent non-invasive sensing of isolated heart function
Diedrich et al. Reliability of left atrial pressure estimation from left ventricular filling measurement in a total artificial heart
Desaive et al. Study of ventricular interaction during pulmonary embolism using clinical identification in a minimum cardiovascular system model
Alonazi et al. Simulation of motor current waveforms in monitoring aortic valve state during ventricular assist device support

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160406

Termination date: 20210806

CF01 Termination of patent right due to non-payment of annual fee